What is the Medicare Donut Hole?
Medicare's Donut Hole (aka the Coverage Gap) is a term that prompts curiosity or apprehension among Medicare beneficiaries. The cake donut is generally round with an empty center or hole. There is something to eat on both sides and nothing in the middle. This metaphorically describes a gap in a prescription drug plan's paying for drug coverage, with beneficiaries paying generally more for drugs than in other drug stages. Medicare's Donut Hole (Coverage Gap) is third of four stages of drug coverage that PDPs must include in their structure.
Medicare mandates that all beneficiaries have prescription drug coverage, which could be in the form of a stand-alone prescription drug plan for a monthly premium or embedded in a Medicare Advantage HMO or PPO. Beneficiaries may have other creditable drug coverage through their employer group, Veterans benefits, Federal Employee Health Benefits Program, CHAMPVA, TRICARE, or
In stage one, the Deductible Phase, the beneficiary bears the full cost of drugs until the deductible is satisfied. Medicare caps this deductible annually: plans may charge Medicare's full deductible, a lesser deductible, or none. If a PDP has no deductible, the next stage is the Initial Coverage Phase (Stage two.) Here both beneficiary and plan share the cost of drugs up to a threshold established annually by Medicare. This is the first side of our cake donut.
When the beneficiary and plan's share of the cost of drugs reach the threshold, the beneficiary enters the Donut Hole or Coverage Gap Phase (Stage three.) The beneficiary pays a percentage of the full cost of a generic. The same percentage applies to brand name drugs with the aid of a manufacturer's discount. The member, if taking expensive drugs, generally pays a higher cost for his medicine. When the beneficiary's costs reach Medicare's final threshold, relief is in sight. At the Catastrophic Stage, the plan pays the majority of the drug costs thereafter. The grateful beneficiary pays a much lower coinsurance for a generic or brand name drug. The last side of the donut tastes great!
Prescription drug plans are complex. To learn more about PDPs, consult www.medicare.gov or call 1-800-MEDICARE. (TTY users should call 1-877-486-2048) 24 hours a day/7 days a week.



What happens if no one claims the Mega Millions jackpot?
Hospitals finally face the music on price transparency
Advisor News
- Business owners may be overlooking a key part of their financial picture
- How smart investments prepare clients for inflation
- Amid slew of corporate tax ideas, Newsom chose one likely to hit people’s premiums
- The biggest risk to your clients’ financial plans isn’t market volatility
- Initiative looks at how caregiving impacts workplace benefits
More Advisor NewsAnnuity News
- Best’s Special Report: U.S. Life/Annuity Industry Sees Bottom-Line Growth Despite 18% Decline in Total Income in First-Quarter 2026
- Globe Life Inc. (NYSE: GL) Records 52-Week High Thursday Morning
- Fortitude Re Completes $500 Million FABN Issuance
- Reframing retirement income for greater certainty
- Jackson Introduces Dow Jones Industrial Average Index Option, Flexible Premiums, Six-Year Rate Guarantee in Latest Registered Index-Linked Annuity Launch
More Annuity NewsHealth/Employee Benefits News
- A Swansea woman's health insurance saga: Breast cancer leads to bankruptcy
- SEN. OSSOFF WORKING ACROSS THE AISLE TO LOWER HEALTH CARE COSTS FOR MILITARY FAMILIES
- Inovaare Expands AI-Native BPaaS for U.S. Health Plans, Defining the Third Generation of Payer Operations
- AuguStar Life enhances its suite of living benefits
- Final rules for Medicaid work requirements are out. Here's what you need to know.
More Health/Employee Benefits NewsLife Insurance News
- Greg Lindberg slams ‘vindictiveness’ in fight for prison computer access
- Best’s Special Report: U.S. Life/Annuity Industry Sees Bottom-Line Growth Despite 18% Decline in Total Income in First-Quarter 2026
- AuguStar Life enhances its suite of living benefits
- Lobbyist argues Iowa insurance regulator gives too much voice to Wall Street
- Appeals court rejects investor payouts in latest decision against STOLI
More Life Insurance News